WA
ADPT icon

Wasatch Advisors’s Adaptive Biotechnologies ADPT Stock Holding History

Wasatch Advisors’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.4M Buy
+576,266
New +$8.83M 0.08% 132
2019
Q4 		– Sell
-49,988
Closed -$1.54M – 246
2019
Q3 		$1.54M Sell
49,988
-512
-1% -$20.9K 0.01% 232
2019
Q2 		$2.44M Buy
+50,500
New +$2.24M 0.02% 216

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wasatch Advisors's ADPT Position: Q2 2026 in Review

Wasatch Advisors opened a new position in Adaptive Biotechnologies (ADPT) in Q2 2026: 576,266 shares worth $12.4M. The stake represents 0.08% of the portfolio and ranks #132 among its holdings. This is a return to the name: Wasatch Advisors previously reported a position in ADPT as recently as Q3 2019.

Wasatch Advisors first reported a position in ADPT in Q2 2019 and has held it in 3 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Wasatch Advisors held 576,266 shares of Adaptive Biotechnologies worth $12.4M as of Q2 2026.
  • Adaptive Biotechnologies was a new Wasatch Advisors position in Q2 2026.
  • Adaptive Biotechnologies made up 0.08% of Wasatch Advisors's portfolio in Q2 2026, its #132 holding.
  • Wasatch Advisors first reported a position in Adaptive Biotechnologies in Q2 2019 and has held it in 3 quarters since.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Wasatch Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.